Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels

Molecular and Cellular Biology

Volumn 25, Issue 3, 2005, Pages 1100-1112

  Topisirovic, Ivan ^a,c   Kentsis, Alex ^a   Perez, Jacqueline M ^a   Guzman, Monica L ^b   Jordan, Craig T ^b   Borden, Katherine L B ^a,c  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; HOMEODOMAIN PROTEIN; INITIATION FACTOR 4E; MESSENGER RNA; ORNITHINE DECARBOXYLASE; PROLINE; PROTEIN HOXA9; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CARCINOGENESIS; CELL NUCLEUS; CYTOPLASM; EUKARYOTE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSLATION INITIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ACUTE DISEASE; AMINO ACID SEQUENCE; BONE MARROW CELLS; CELL NUCLEUS; CYCLIN D1; CYTOPLASM; EUKARYOTIC INITIATION FACTOR-4E; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; MOLECULAR SEQUENCE DATA; ORNITHINE DECARBOXYLASE; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 12844255862     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.3.1100-1112.2005     Document Type: Article

References (36)

1. Borden, K. L. 2002. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22:5259-5269.
2. Calvo, K. R., D. B. Sykes, M. Pasillas, and M. P. Kamps. 2000. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced Meis expression. Mol. Cell. Biol. 20:3274-3285.
3. Carlile, G. W., W. G. Tatton, and K. L. Borden. 1998. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase. Biochem. J. 335:691-696.
4. Clemens, M. J., and U. A. Bommer. 1999. Translational control: the cancer connection. Int. J. Biochem. Cell Biol. 31:1-23.
5. Cohen, N., M. Sharma, A. Kentsis, J. M. Perez, S. Strudwick, and K. L. Borden. 2001. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. EMBO J. 20:4547-4559.
6. Culjkovic, B., I. Topisriovic, L. Skrabanek, M. Ruiz-Gutierrez, and K. L. B. Borden. eIF4E selectively associates with nuclear mRNAs with a novel 3′UTR structure to modulate their nucleo-cytoplasmic mRNA transport. Submitted for publication.
7. De Benedetti, A., and A. L. Harris. 1999. eIF4E expression in tumors: its possible role in progression and malignancies. Int. J. Biochem. Cell Biol. 31:59-72.
8. Golub, T. R., D. K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J. P. Mesirov, H. Coller, M. L. Loh, J. R. Downing, M. A. Caligiuri, C. D. Bloomfield, and E. S. Lander. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537.
9. Graff, J. R., and S. G. Zimmer. 2003. Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin. Exp. Metastasis 20:265-273.
10. Gross, J. D., N. J. Moerke, T. von der Haar, A. A. Lugovskoy, A. B. Sachs, J. E. McCarthy, and G. Wagner. 2003. Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E. Cell 115:739-750.
11. Guzman, M. L., C. F. Swiderski, D. S. Howard, B. A. Grimes, R. M. Rossi, S. J. Szilvassy, and C. T. Jordan. 2002. Preferential induction of apoptosis for primary human leukemic stem cells. Proc. Natl. Acad. Sci. USA 99:16220-16225.
12. Iborra, F. J., D. A. Jackson, and P. R. Cook. 2001. Coupled transcription and translation within nuclei of mammalian cells. Science 293:1139-1142.
13. Jordan, C. T., D. Upchurch, S. J. Szilvassy, M. L. Guzman, D. S. Howard, A. L. Pettigrew, T. Meyerrose, R. Rossi, B. Grimes, D. A. Rizzieri, S. M. Luger, and G. L. Phillips. 2000. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14:1777-1784.
14. Kentsis, A., E. C. Dwyer, J. M. Perez, M. Sharma, A. Chen, Z. Q. Pan, and K. L. Borden. 2001. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein z repress translation by directly inhibiting translation initiation factor eIF4E. J. Mol. Biol. 312:609-623.
15. Kentsis, A., R. E. Gordon, and K. L. Borden. 2002. Control of biochemical reactions through supramolecular RING domain self-assembly. Proc. Natl. Acad. Sci. USA 99:15404-15409.
16. Kroon, E., J. Krosl, U. Thorsteinsdottir, S. Baban, A. M. Buchberg, and G. Sauvageau. 1998. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17:3714-3725.
17. Lai, H. K., and K. L. Borden. 2000. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA. Oncogene 19:1623-1634.
18. Lawrence, H. J., S. Rozenfeld, C. Cruz, K. Matsukuma, A. Kwong, L. Komuves, A. M. Buchberg, and C. Largman. 1999. Frequent coexpression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13:1993-1999.
19. Lazaris-Karatzas, A., K. S. Montine, and N. Sonenberg. 1990. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544-547.
20. Lazaris-Karatzas, A., M. R. Smith, R. M. Frederickson, M. L. Jaramillo, Y. L. Liu, H. F. Kung, and N. Sonenberg. 1992. Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev. 6:1631-1642.
21. Lazaris-Karatzas, A., and N. Sonenberg. 1992. The mRNA 5′ cap-binding protein, eIF-4E, cooperates with v-myc or EIA in the transformation of primary rodent fibroblasts. Mol. Cell. Biol. 12:1234-1238.
22. Lejbkowicz, F., C. Goyer, A. Darveau, S. Neron, R. Lemieux, and N. Sonenberg. 1992. A fraction of the mRNA 5′ cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. Proc. Natl. Acad. Sci. USA 89:9612-9616.
23. Nathan, C. A., P. Carter, L. Liu, B. D. Li, F. Abreo, A. Tudor, S. G. Zimmer, and A. De Benedetti. 1997. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene 15:1087-1094.
24. Niessing, D., S. Blanke, and H. Jackle. 2002. Bicoid associates with the 5′-cap-bound complex of caudal mRNA and represses translation. Genes Dev. 16:2576-2582.
25. Niessing, D., N. Dostatni, H. Jackle, and R. Rivera-Pomar. 1999. Sequence interval within the PEST motif of Bicoid is important for translational repression of caudal mRNA in the anterior region of the Drosophila embryo. EMBO J. 18:1966-1973.
26. Prochiantz, A., and A. Joliot. 2003. Can transcription factors function as cell-cell signaling molecules? Nat. Rev. Mol. Cell. Biol. 4:814-819.
27. Rousseau, D., R. Kaspar, I. Rosenwald, L. Gehrke, and N. Sonenberg. 1996. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. USA 93:1065-1070.
28. Sonenberg, N., and A. C. Gingras. 1998. The mRNA 5′ cap-binding protein CIF4E and control of cell growth. Curr. Opin. Cell Biol. 10:268-275.
29. Strudwick, S., and K. L. Borden. 2002. The emerging roles of translation factor eIF4E in the nucleus. Differentiation 70:10-22.
30. Thorsteinsdottir, U., E. Kroon, L. Jerome, F. Blasi, and G. Sauvageau. 2001. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol. Cell. Biol. 21:224-234.
31. Topcu, Z., D. L. Mack, R. A. Hromas, and K. L. Borden. 1999. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control. Oncogene 18:7091-7100.
32. Topisirovic, I., A. D. Capili, and K. L. Borden. 2002. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner. Mol. Cell. Biol. 22:6183-6198.
33. Topisirovic, I., B. Culjkovic, N. Cohen, J. M. Perez, L. Skrabanek, and K. L. Borden. 2003. The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth. EMBO J. 22:689-703.
34. Topisirovic, I., M. L. Guzman, M. J. McConnell, J. D. Licht, B. Culjkovic, S. J. Neering, C. T. Jordan, and K. L. Borden. 2003. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis. Mol. Cell. Biol. 23:8992-9002.
35. Wang, S., I. B. Rosenwald, M. J. Hutzler, G. A. Pihan, L. Savas, J. J. Chen, and B. A. Woda. 1999. Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am. J. Pathol. 155:247-255.
36. Zuberek, J., J. Jemielity, A. Jablonowska, J. Stepinski, M. Dadlez, R. Stolarski, and E. Darzynkiewicz. 2004. Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5′ terminus. Biochemistry 43:5370-5379.